INR 10.57
(0.67%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 85.73 Million | 184.98 Million | 97.3 Million | 140.26 Million | 117.65 Million | 144.24 Million |
Net Income | 62.03 Million | 61.37 Million | 82.08 Million | 55.5 Million | 51.89 Million | 38.33 Million |
Depreciation & Amortization | 75.52 Million | 70.15 Million | 62.58 Million | 59.26 Million | 62.45 Million | 39.3 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -71.55 Million | 57.55 Million | -49.94 Million | 23.57 Million | 3.3 Million | 66.61 Million |
Other non-cash items | 271.81 Million | -4.1 Million | 2.58 Million | 1.92 Million | 2.00 | 81.3 Million |
Investing Cash Flow | -105.34 Million | -240.34 Million | -71.32 Million | -59.38 Million | -118.74 Million | -147.46 Million |
Investments in PPE | -35.24 Million | -241.12 Million | -103.34 Million | -32.01 Million | -124.97 Million | -249.7 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -70.1 Million | - | - | -29.64 Million | - | - |
Sales/Maturities of investments | - | - | 31.3 Million | - | 6.22 Million | 1.43 Million |
Other Investing Activities | -68.63 Million | 777 Thousand | 713.99 Thousand | 2.27 Million | 1.69 Million | 100.8 Million |
Financing Cash Flow | 15.42 Million | 64.54 Million | -34.88 Million | -73.55 Million | -59.29 Million | 100.8 Million |
Debt repayment | -15.32 Million | -81.32 Million | -21.21 Million | -54.95 Million | -33.61 Million | -37.61 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 100 Thousand | - | - | - | - | - |
Other Financing Activities | 1000.00 | 145.86 Million | -13.67 Million | -18.59 Million | -25.68 Million | 138.41 Million |
Accounts receivables | -91.71 Million | 56.54 Million | -63.47 Million | 23.49 Million | 7.86 Million | 3.11 Million |
Accounts payables | -9.31 Million | 11.18 Million | 5.59 Million | -2.42 Million | 11 Million | -602.6 Thousand |
Inventory | - | -11.18 Million | -5.59 Million | 2.42 Million | -11 Million | 602.6 Thousand |
Other working capital | 29.47 Million | 1.01 Million | 13.52 Million | 83.36 Thousand | -4.55 Million | 63.49 Million |
Cash at beginning of period | 12.55 Million | 3.37 Million | 12.29 Million | 4.96 Million | 6.05 Million | 9.27 Million |
Cash at end of period | 8.37 Million | 12.55 Million | 3.37 Million | 12.29 Million | 4.96 Million | 6.05 Million |
Capital Expenditure | -35.24 Million | -241.12 Million | -103.34 Million | -32.01 Million | -124.97 Million | -249.7 Million |
Effect of forex changes on cash | - | 40.00 | 500.00 | 2.00 | 59.29 Million | -100.8 Million |
Net cash flow / Change in cash | -4.18 Million | 9.17 Million | -8.91 Million | 7.32 Million | -1.08 Million | -3.21 Million |
Free Cash Flow | 50.49 Million | -56.14 Million | -6.04 Million | 108.25 Million | -7.31 Million | -105.45 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 11.96 Million | 62.03 Million | 35.05 Million | 4.06 Million | 12.56 Million | 10.35 Million |
Depreciation & Amortization | - | 75.52 Million | - | 19.5 Million | 36.38 Million | 17.96 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -71.55 Million | - | - | 225 Thousand | - |
Other non-cash items | -11.96 Million | 271.81 Million | -35.05 Million | -4.06 Million | -12.56 Million | -10.35 Million |
Investing Cash Flow | - | -105.34 Million | - | - | -19.25 Million | - |
Investments in PPE | - | -35.24 Million | - | - | -19.35 Million | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -70.1 Million | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -68.63 Million | - | - | 104 Thousand | - |
Financing Cash Flow | - | 15.42 Million | - | - | -63.98 Million | - |
Debt repayment | - | -15.32 Million | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 100 Thousand | - | - | - | - |
Other Financing Activities | - | 1000.00 | - | - | -63.98 Million | - |
Accounts receivables | - | -91.71 Million | - | - | 225 Thousand | - |
Accounts payables | - | -9.31 Million | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | 29.47 Million | - | - | - | - |
Cash at beginning of period | - | 12.55 Million | - | 1.37 Million | - | 12.55 Million |
Cash at end of period | - | 8.37 Million | - | 40.38 Million | 1.37 Million | 48.49 Million |
Capital Expenditure | - | -35.24 Million | - | - | -19.35 Million | - |
Effect of forex changes on cash | - | - | - | - | 12.55 Million | - |
Net cash flow / Change in cash | - | -4.18 Million | - | 39 Million | 1.37 Million | 35.93 Million |
Free Cash Flow | - | 50.49 Million | - | 39 Million | 52.7 Million | 35.93 Million |
WA8
SESPF
SUNPHARMA
MIL
OERCF
HOTEL